- ABBV has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $422.2 million.
- ABBV has traded 3,652 shares today.
- ABBV is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ABBV with the Ticky from Trade-Ideas. See the FREE profile for ABBV NOW at Trade-Ideas More details on ABBV: AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The stock currently has a dividend yield of 3%. ABBV has a PE ratio of 28.5. Currently there are 7 analysts that rate AbbVie a buy, no analysts rate it a sell, and 3 rate it a hold. The average volume for AbbVie has been 13.5 million shares per day over the past 30 days. AbbVie has a market cap of $104.4 billion and is part of the health care sector and drugs industry. Shares are up 23.4% year-to-date as of the close of trading on Thursday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. TheStreetRatings.com Analysis: TheStreet Quant Ratings rates AbbVie as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and weak operating cash flow.